Invention Grant
- Patent Title: Pyrimidine carboxamides as GSK-3 inhibitors
-
Application No.: US16463603Application Date: 2017-11-27
-
Publication No.: US11053258B2Publication Date: 2021-07-06
- Inventor: Guanglin Luo , Prasanna Sivaprakasam , Gene M. Dubowchik , John E. Macor
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen; Shrikant M. Kulkarni
- International Application: PCT/US2017/063232 WO 20171127
- International Announcement: WO2018/098413 WO 20180531
- Main IPC: C07D498/18
- IPC: C07D498/18 ; C07D471/22 ; C07D498/22 ; A61P25/28 ; A61P25/16 ; A61P25/14
Abstract:
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds to treat disorders associated with GSK-3.
Public/Granted literature
- US20200181170A1 PYRIMIDINE CARBOXAMIDES AS GSK-3 INHIBITORS Public/Granted day:2020-06-11
Information query
